Back to Browse Journals » OncoTargets and Therapy » Volume 10 » default

OncoTargets and Therapy


Archive: Volume 10, 2017

FBLN4 as candidate gene associated with long-term and short-term survival with primary glioblastoma

Li F, Li YP, Zhang K, Li Y, He P, Liu YJ, Yuan H, Lu H, Liu J, Che S, Li Z, Bie L

OncoTargets and Therapy 2017, 10:387-395

Published Date: 16 January 2017

Overall survival in renal cell carcinoma after introduction of targeted therapies: a Norwegian population-based study

Beisland C, Johannesen TB, Klepp O, Axcrona U, Torgersen KM, Kowalski J, Solli O, Sandin R, Oldenburg J

OncoTargets and Therapy 2017, 10:371-385

Published Date: 16 January 2017

Validation of a novel prognostic scoring system using inflammatory response biomarkers in patients undergoing curative thoracoscopic esophagectomy for esophageal squamous cell carcinoma

Hirahara N, Fujii Y, Yamamoto T, Hyakudomi R, Hirayama T, Taniura T, Ishitobi K, Tajima Y

OncoTargets and Therapy 2017, 10:363-370

Published Date: 13 January 2017

Advances in antiangiogenic treatment of small-cell lung cancer

Lu H, Jiang Z

OncoTargets and Therapy 2017, 10:353-359

Published Date: 12 January 2017

Chidamide in the treatment of peripheral T-cell lymphoma

Chan TS, Tse E, Kwong YL

OncoTargets and Therapy 2017, 10:347-352

Published Date: 12 January 2017

Decrease of RBM4 indicates poor prognosis in patients with hepatocellular carcinoma after hepatectomy

Chen J, Liu L, Xu J

OncoTargets and Therapy 2017, 10:339-345

Published Date: 11 January 2017

Radiosynthesis and pharmacokinetics of [18F]fluoroethyl bufalin in hepatocellular carcinoma-bearing mice

Yang Z, Liu J, Huang Q, Zhang Z, Zhang J, Pan Y, Yang Y, Cheng D

OncoTargets and Therapy 2017, 10:329-338

Published Date: 11 January 2017

Prognostic value and clinicopathological significance of proliferating cell nuclear antigen expression in gastric cancer: a systematic review and meta-analysis

Yin SC, Li Z, Huang JY, Miao ZF, Zhang JY, Lu CY, Xu H, Xu HM

OncoTargets and Therapy 2017, 10:319-327

Published Date: 10 January 2017

Expression of phosphatase of regenerating liver-3 is associated with prognosis of Wilms’ tumor

Sun F, Li W, Wang L, Jiao C

OncoTargets and Therapy 2017, 10:311-317

Published Date: 10 January 2017

Association of MTHFR C677T and A1298C polymorphisms with oral cancer susceptibility: evidence from a meta-analysis

Jiang S, Xu J, Zhuo Z, Hua Z

OncoTargets and Therapy 2017, 10:303-310

Published Date: 10 January 2017

Clinical outcomes of patients with metachronous second primary lung adenocarcinomas

Zhao H, Yang H, Han K, Xu J, Yao F, Zhao Y, Fan L, Gu H, Shen Z

OncoTargets and Therapy 2017, 10:295-302

Published Date: 10 January 2017

Correlation of SASH1 expression and ultrasonographic features in breast cancer

Gong X, Wu J, Wu J, Liu J, Gu H, Shen H

OncoTargets and Therapy 2017, 10:271-276

Published Date: 10 January 2017

Strategies of temozolomide in future glioblastoma treatment

Lee CY

OncoTargets and Therapy 2017, 10:265-270

Published Date: 9 January 2017

RASSF1A promoter methylation is associated with increased risk of thyroid cancer: a meta-analysis

Shou FY, Xu F, Li G, Zhao ZH, Mao Y, Yang FF, Wang HM, Guo HY

OncoTargets and Therapy 2017, 10:247-257

Published Date: 9 January 2017

Clinical outcomes of epidermal growth factor receptor tyrosine kinase inhibitors in recurrent adenosquamous carcinoma of the lung after resection

Fan L, Yang H, Yao F, Zhao Y, Gu H, Han K, Zhao H

OncoTargets and Therapy 2017, 10:239-245

Published Date: 6 January 2017

VTD-melphalan is well tolerated and results in very high rates of stringent CR and MRD-negative status in multiple myeloma

Nadiminti K, Singh Abbi KK, Mott SL, Dozeman L, Tricot A, Schultz A, Behrends S, Zhan F, Tricot G

OncoTargets and Therapy 2017, 10:217-226

Published Date: 6 January 2017

Long noncoding RNA CRNDE functions as a competing endogenous RNA to promote metastasis and oxaliplatin resistance by sponging miR-136 in colorectal cancer

Gao H, Song X, Kang T, Yan B, Feng L, Gao L, Ai L, Liu X, Yu J, Li H

OncoTargets and Therapy 2017, 10:205-216

Published Date: 5 January 2017

Multivoxel magnetic resonance spectroscopy identifies enriched foci of cancer stem-like cells in high-grade gliomas

He T, Qiu T, Wang X, Gui H, Wang X, Hu Q, Xia H, Qi G, Wu J, Ma H

OncoTargets and Therapy 2017, 10:195-203

Published Date: 4 January 2017

The role of microRNA-21 in predicting brain metastases from non-small cell lung cancer

Dong J, Zhang Z, Gu T, Xu SF, Dong LX, Li X, Fu BH, Fu ZZ

OncoTargets and Therapy 2017, 10:185-194

Published Date: 29 December 2016

Pediatric papillary thyroid cancer: current management challenges

Verburg FA, Van Santen HM, Luster M

OncoTargets and Therapy 2017, 10:165-175

Published Date: 28 December 2016

Clinicopathological and immunohistochemical features of lung invasive mucinous adenocarcinoma based on computed tomography findings

Shimizu K, Okita R, Saisho S, Maeda A, Nojima Y, Nakata M

OncoTargets and Therapy 2017, 10:153-163

Published Date: 28 December 2016

Recombinant human endostatin in combination with CHOP regimen for peripheral T cell lymphoma

Zhang Q, Cao J, Xue K, Liu X, Ji D, Guo Y, Hong X

OncoTargets and Therapy 2017, 10:145-151

Published Date: 22 December 2016

Anticancer activities of epigallocatechin-3-gallate against cholangiocarcinoma cells

Kwak TW, Park SB, Kim HJ, Jeong YI, Kang DH

OncoTargets and Therapy 2017, 10:137-144

Published Date: 22 December 2016

High expression of long noncoding RNA HULC is a poor predictor of prognosis and regulates cell proliferation in glioma

Yan H, Tian R, Zhang M, Wu J, Ding M, He J

OncoTargets and Therapy 2017, 10:113-120

Published Date: 21 December 2016

Expression of HPIP in epithelial ovarian carcinoma: a clinicopathological study

Wang Y, Meng F, Liu Y, Chen X

OncoTargets and Therapy 2017, 10:95-100

Published Date: 20 December 2016

Reduction of AZGP1 predicts poor prognosis in esophageal squamous cell carcinoma patients in Northern China

Tang H, Wu Y, Qin Y, Wang H, Wang L, Guan X, Luo S, Wang Q

OncoTargets and Therapy 2017, 10:85-94

Published Date: 20 December 2016

RANKL/RANK pathway abrogates cetuximab sensitivity in gastric cancer cells via activation of EGFR and c-Src

Zhang X, Song Y, Song N, Zhang Y, Zhang L, Wang Y, Wang Z, Qu X, Liu Y

OncoTargets and Therapy 2017, 10:73-83

Published Date: 5 January 2017

Nasopharyngeal carcinoma treated with bevacizumab combined with paclitaxel liposome plus cisplatin: a case report and literature review

He W, Zou C, Tian ZK, Tan WY, Shen WX, Chen JH, Liu LP, Xu RL

OncoTargets and Therapy 2017, 10:67-72

Published Date: 20 December 2016

Low PLCE1 levels are correlated with poor prognosis in hepatocellular carcinoma

Cheng Y, Xing SG, Jia WD, Huang M, Bian NN

OncoTargets and Therapy 2017, 10:47-54

Published Date: 19 December 2016

Long noncoding RNA MALAT1-regulated microRNA 506 modulates ovarian cancer growth by targeting iASPP

Lei R, Xue M, Zhang L, Lin ZQ

OncoTargets and Therapy 2017, 10:35-46

Published Date: 19 December 2016

Atypical aleukemic presentation of large granular lymphocytic leukemia: a case report

Bagacean C, Tempescul A, Patiu M, Fetica B, Bumbea H, Zdrenghea M

OncoTargets and Therapy 2017, 10:31-34

Published Date: 19 December 2016

Potential role of immunotherapy in advanced non-small-cell lung cancer

de Mello RA, Veloso AF, Esrom Catarina P, Nadine S, Antoniou G

OncoTargets and Therapy 2017, 10:21-30

Published Date: 16 December 2016

J-pouch versus Roux-en-Y reconstruction after gastrectomy: functional assessment and quality of life (randomized trial)

Zonca P, Maly T, Ihnat P, Peteja M, Kraft O, Kuca K

OncoTargets and Therapy 2017, 10:13-19

Published Date: 16 December 2016

Association between TLR-9 polymorphisms and colon cancer susceptibility in Saudi Arabian female patients

Semlali A, Parine NR, Al Amri A, Azzi A, Arafah M, Kohailan M, Shaik JP, Almadi MA, Aljebreen AM, Alharbi O, Ali Azzam N, Rouabhia M, Alanazi MS

OncoTargets and Therapy 2017, 10:1-11

Published Date: 16 December 2016